Heterodimeric IL-15 in Cancer Immunotherapy

SIMPLE SUMMARY: The rapidly expanding field of cancer immunotherapy uses diverse technologies, including cytokines, T cells, and antibody administration, with the aim to induce effective immune responses leading to tumor control. Interleukin-15 (IL-15), a cytokine discovered in 1994, supports the ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergamaschi, Cristina, Stravokefalou, Vasiliki, Stellas, Dimitris, Karaliota, Sevasti, Felber, Barbara K., Pavlakis, George N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922495/
https://www.ncbi.nlm.nih.gov/pubmed/33671252
http://dx.doi.org/10.3390/cancers13040837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922495/
https://www.ncbi.nlm.nih.gov/pubmed/33671252
http://dx.doi.org/10.3390/cancers13040837

Ejemplares similares